Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods

TV Mashel, YV Tarakanchikova, AR Muslimov… - Biomaterials, 2020 - Elsevier
Besides its broad application in research and biotechnology, genome editing (GE) has great
potential for clinical gene therapy, but delivery of GE tools remains a bottleneck. Whereas …

Material solutions for delivery of CRISPR/Cas-based genome editing tools: Current status and future outlook

T Wan, D Niu, C Wu, FJ Xu, G Church, Y Ping - Materials Today, 2019 - Elsevier
Clustered regularly interspaced short palindromic repeat (CRISPR)/associated protein
(CRISPR/Cas) system is an adaptable immune mechanism used by many bacteria to protect …

Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer

W Ma, Q Chen, W Xu, M Yu, Y Yang, B Zou, YS Zhang… - Nano Research, 2021 - Springer
Multidrug-resistance (MDR) featuring complicated and poorly defined mechanisms is a
major obstacle to the success of cancer chemotherapy in the clinic. Compound …

Self‐stabilized hyaluronate nanogel for intracellular codelivery of doxorubicin and cisplatin to osteosarcoma

Y Zhang, F Wang, M Li, Z Yu, R Qi, J Ding… - Advanced …, 2018 - Wiley Online Library
Osteosarcoma is one of the most serious bone malignancies with rapid speed of
deterioration and low survival rate in children and teenagers. Chemotherapy is an important …

[HTML][HTML] Sarcoma-targeting peptide-decorated polypeptide nanogel intracellularly delivers shikonin for upregulated osteosarcoma necroptosis and diminished …

S Li, T Zhang, W Xu, J Ding, F Yin, J Xu, W Sun… - Theranostics, 2018 - ncbi.nlm.nih.gov
Purpose: Osteosarcoma is the most common primary bone cancer and is notorious for
pulmonary metastasis, representing a major threat to pediatric patients. An effective drug …

Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas

Y Zhang, L Cai, D Li, YH Lao, D Liu, M Li, J Ding… - Nano Research, 2018 - Springer
Osteosarcoma is the most common malignancy in the bone. Current chemotherapy offers
limited efficacy with significant side effects, especially for advanced and relapsed …

Injectable hydrogel–microsphere construct with sequential degradation for locally synergistic chemotherapy

Y Zheng, Y Cheng, J Chen, J Ding, M Li… - … applied materials & …, 2017 - ACS Publications
In recent years, in situ chemotherapy mediated by biodegradable polymer platforms has
attracted increased attention. Herein, an advanced drug delivery system, combretastatin A-4 …

Advances in stimuli‐responsive polypeptide nanogels

Z Jiang, J Chen, L Cui, X Zhuang, J Ding… - Small …, 2018 - Wiley Online Library
Polymer nanogels, which are nanosized particles of hydrogels formed by physically or
chemically crosslinking polymers, are one of the most promising nanoplatforms for use in …

3D-printing magnesium–polycaprolactone loaded with melatonin inhibits the development of osteosarcoma by regulating cell-in-cell structures

W Zhang, W Zhao, Q Li, D Zhao, J Qu, Z Yuan… - Journal of …, 2021 - Springer
Melatonin has been proposed as a potent anticarcinogen presents a short half-life for
osteosarcoma (OS). Cell-in-cell (CIC) structures play a role in the development of malignant …

Evaluation of boron nitride nanotubes and hexagonal boron nitrides as nanocarriers for cancer drugs

M Emanet, Ö Şen, M Çulha - Nanomedicine, 2017 - Taylor & Francis
Aim: Boron nitride nanotubes (BNNTs) and hexagonal boron nitrides (hBNs) are novel
nanostructures with high mechanical strengths, large surface areas and excellent …